InPharmd
inpharmd.comX / TwitterLinkedIn

Developing an AI-based medical application designed to answer clinical questions or drug formulary requests with custom data.

Founders
Ashish AdvaniTulasee Chintha
645 Deal Team
Pete Keenan
Industry
Health Tech
Entry Stage
Seed
Status
Active
Investment Date
2023
Company Overview

InPharmD is developing an AI-based medical application that answers clinical questions and drug formulary requests using custom institutional data. The tool is designed to support pharmacists and clinicians with rapid, evidence-based responses at the point of care.

Investment Rationale

InpharmD offers an AI-powered platform that provides instant, high-quality clinical insights to pharmacists, dramatically improving medication therapy optimization and enabling faster, more accurate patient care. CEO Ashish Advani, a clinical pharmacist and former professor, brings deep domain expertise and strong perseverance. He has a deep understanding of the problems faced by pharmacists that AI can solve, and is dedicated to solving them. Legacy players like UpToDate and Lexicomp are outdated and cumbersome. InpharmD offers a 10x better experience, with direct, AI-driven answers that save hundreds of hours for healthcare providers.